Free Trial

Knight Therapeutics (KHTRF) Short Interest Ratio & Short Volume

Knight Therapeutics logo
$3.78 +0.09 (+2.44%)
(As of 11/18/2024 ET)

Knight Therapeutics Short Interest Data

Knight Therapeutics (KHTRF) has a short interest of 345,200 shares. This marks a 34.79% increase in short interest from the previous month. The short interest ratio (days to cover) is 119.0, indicating that it would take 119.0 days of the average trading volume of 5,958 shares to cover all short positions.

Current Short Interest
345,200 shares
Previous Short Interest
256,100 shares
Change Vs. Previous Month
+34.79%
Dollar Volume Sold Short
$1.39 million
Short Interest Ratio
119.0 Days to Cover
Last Record Date
October 31, 2024
Today's Trading Volume
6,442 shares
Average Trading Volume
5,958 shares
Today's Volume Vs. Average
108%
Short Selling Knight Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Knight Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

KHTRF Short Interest Over Time

KHTRF Days to Cover Over Time

KHTRF Percentage of Float Shorted Over Time

Knight Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/2024345,200 shares $1.39 million +34.8%N/A119 $4.04
10/15/2024256,100 shares $1.07 million +17.4%N/A128.1 $4.19
9/30/2024218,100 shares $950,916.00 -0.2%N/A94.8 $4.36
9/15/2024218,600 shares $966,212.00 +5.5%N/A128.6 $4.42
8/31/2024207,300 shares $852,003.00 +1.3%N/A76.8 $4.11
8/15/2024204,600 shares $840,906.00 -2.7%N/A55.3 $4.11
7/31/2024210,300 shares $868,539.00 -0.8%N/A70.1 $4.13
7/15/2024211,900 shares $885,742.00 -0.4%N/A40 $4.18
6/30/2024212,700 shares $882,705.00 -2.0%N/A44.3 $4.15
6/15/2024217,000 shares $902,720.00 -3.6%N/A433.9 $4.16
5/31/2024225,000 shares $983,475.00 +4.8%N/A59.2 $4.37
5/15/2024214,700 shares $942,533.00 -3.0%N/A55.1 $4.39
4/30/2024221,400 shares $927,666.00 +2.0%N/A82 $4.19
4/15/2024217,000 shares $909,230.00 +3.8%N/A47.2 $4.19
3/31/2024209,100 shares $819,672.00 -0.1%N/A7.1 $3.92
3/15/2024209,300 shares $830,921.00 -10.4%N/A33.8 $3.97
2/29/2024233,600 shares $955,424.00 -8.1%N/A21 $4.09
2/15/2024254,300 shares $1.04 million -0.9%N/A68.7 $4.11
1/15/2024230,500 shares $965,564.50 -2.9%N/A74.3 $4.19
12/31/2023237,300 shares $939,708.00 -2.4%N/A92.4 $3.96
12/15/2023243,100 shares $940,553.90 -45.2%N/A47.7 $3.87
11/30/2023443,500 shares $1.72 million -7.7%N/A119.9 $3.88
11/15/2023480,300 shares $1.81 million -19.4%N/A64.9 $3.76
10/31/2023596,000 shares $1.94 million +103.6%N/A220.7 $3.26
10/15/2023292,800 shares $983,808.00 +11.2%N/A6.6 $3.36
9/30/2023263,400 shares $874,539.10 -32.5%N/A39.3 $3.32
9/15/2023390,400 shares $1.28 million +6.7%N/A61 $3.29
8/31/2023366,000 shares $1.25 million +16.0%N/A8715.1 $3.41
8/15/2023315,600 shares $1.04 million -8.8%N/A3156 $3.31
7/31/2023345,900 shares $1.27 million +19.7%N/A150.4 $3.66
7/15/2023289,100 shares $1.09 million -3.2%N/A321.2 $3.78
6/30/2023298,600 shares $1.08 million +42.3%N/A64.9 $3.62
6/15/2023209,900 shares $761,937.00 -51.7%N/A8.2 $3.63
5/31/2023434,300 shares $1.58 million -29.6%N/A24.3 $3.63
5/15/2023616,700 shares $2.22 million +31.1%N/A1541.8 $3.60
4/30/2023470,400 shares $1.63 million +93.2%N/A470.4 $3.46
4/15/2023243,500 shares $881,470.00 +42.6%N/A19.5 $3.62
3/31/2023170,800 shares $561,078.00 +77.4%N/A27.5 $3.29
3/15/202396,300 shares $351,495.00 -22.0%N/A53.5 $3.65
2/28/2023123,500 shares $463,495.50 -5.6%N/A19.6 $3.75
The pin that pops the AI bubble (Ad)

My new documentary explores the background to this pattern and how and why I believe it will almost certainly repeat itself with the AI frenzy. I urge you to watch it before you invest another cent. Again, to be clear, I’m no Chicken Little. Far from it.

So go here now to read my new report The Big AI Die-Up… while you still can.
2/15/2023130,800 shares $510,460.08 -65.2%N/A1308 $3.90
1/31/2023375,700 shares $1.47 million -16.8%N/A46.4 $3.90
1/15/2023451,300 shares $1.79 million -12.5%N/A161.2 $3.96
12/30/2022515,700 shares $1.96 million +26.0%N/A13.3 $3.80
12/15/2022409,400 shares $1.58 million +69.3%N/A4094 $3.86
11/30/2022241,800 shares $961,880.40 +103.7%N/A2418 $3.98
11/15/2022118,700 shares $472,188.60 -43.1%N/A1187 $3.98
10/31/2022208,500 shares $817,737.00 +37.4%N/A2085 $3.92
10/15/2022151,700 shares $579,038.90 +31.8%N/A758.5 $3.82
9/30/2022115,100 shares $452,688.30 +142.3%N/A115.1 $3.93
9/15/202247,500 shares $220,875.00 -4.6%N/A0 $4.65
8/31/202249,800 shares $231,570.00 +20.3%N/A124.5 $4.65
8/15/202241,400 shares $194,103.90 -42.4%N/A6.2 $4.69
7/31/202271,900 shares $319,955.00 -6.5%N/A359.5 $4.45
7/15/202276,900 shares $332,208.00 -23.8%N/A256.3 $4.32
6/30/2022100,900 shares $401,582.00 -22.2%N/A1009 $3.98
6/15/2022129,600 shares $528,768.00 -19.4%N/A117.8 $4.08
5/31/2022160,700 shares $691,010.00 +10.5%N/A47.3 $4.30
5/15/2022145,400 shares $588,870.00 -2.1%N/A80.8 $4.05
4/30/2022148,500 shares $622,660.50 +2.1%N/A148.5 $4.19
4/15/2022145,500 shares $611,100.00 -51.5%N/A363.8 $4.20
3/31/2022300,100 shares $1.23 million +59.6%N/A1500.5 $4.11
3/15/2022188,000 shares $802,760.00 -8.5%N/A626.7 $4.27
2/28/2022205,500 shares $871,320.00 -6.2%N/A40.3 $4.24
2/15/2022219,000 shares $941,700.00 -33.0%N/A64.4 $4.30
1/31/2022326,900 shares $1.43 million +41.8%N/A155.7 $4.36
1/15/2022230,600 shares $968,520.00 -15.1%N/A2306 $4.20
12/31/2021271,600 shares $1.13 million -5.9%N/A39.9 $4.16
12/15/2021288,500 shares $1.15 million +5.1%N/A72.1 $4.00
11/30/2021274,400 shares $1.12 million -24.0%N/A40.4 $4.10
11/15/2021360,900 shares $1.53 million -14.1%N/A11.2 $4.23
10/29/2021420,100 shares $1.75 million +53.3%N/A131.3 $4.15
10/15/2021274,000 shares $1.18 million -38.8%N/A47.2 $4.32
9/30/2021447,700 shares $1.93 million -7.1%N/A81.4 $4.31
9/15/2021482,000 shares $2.01 million -3.2%N/A150.6 $4.16
8/31/2021497,800 shares $2.11 million -17.6%N/A54.1 $4.25
8/13/2021604,400 shares $2.73 million -6.5%N/A167.9 $4.51
7/30/2021646,700 shares $2.65 million +39.1%N/A6.4 $4.09
7/15/2021464,900 shares $1.94 million +21.9%N/A101.1 $4.18
6/30/2021381,500 shares $1.64 million -34.2%N/A5.5 $4.30
6/15/2021580,000 shares $2.52 million -16.3%N/A1933.3 $4.34
5/28/2021726,100 shares $3.15 million -11.1%N/A907.6 $4.33
5/14/2021817,000 shares $3.52 million +4.4%N/A907.8 $4.31
4/30/2021782,400 shares $3.45 million -25.9%N/A23.9 $4.40
4/15/20211,056,300 shares $4.45 million -7.3%N/A8.1 $4.21
3/31/20211,139,900 shares $4.92 million -19.0%N/A11.5 $4.31
3/15/20211,408,000 shares $5.95 million -26.0%N/A327.4 $4.23
2/26/20211,902,200 shares $8.07 million -5.1%N/A3804.4 $4.24
2/12/20212,004,500 shares $8.90 million -29.7%N/A208.8 $4.44
1/29/20212,852,200 shares $12.06 million -37.9%N/A316.9 $4.23
The pin that pops the AI bubble (Ad)

My new documentary explores the background to this pattern and how and why I believe it will almost certainly repeat itself with the AI frenzy. I urge you to watch it before you invest another cent. Again, to be clear, I’m no Chicken Little. Far from it.

So go here now to read my new report The Big AI Die-Up… while you still can.
1/15/20213,093,500 shares $12.86 million +6.6%N/A499 $4.16
12/31/20204,594,900 shares $19.30 million +48.5%N/A216.7 $4.20
12/15/20203,093,500 shares $12.69 million +6.6%N/A499 $4.10
11/30/20202,903,000 shares $11.84 million +5.1%N/A205.9 $4.08
11/15/20202,763,400 shares $11.41 million +0.1%N/A307 $4.13
10/30/20202,761,100 shares $11.84 million +11.1%N/A13805.5 $4.29
10/15/20202,485,600 shares $10.76 million -6.1%N/A994.2 $4.33
9/30/20202,647,100 shares $11.54 million +0.6%N/A472.7 $4.36
9/15/20202,630,300 shares $12.27 million +1.6%N/A417.5 $4.67
8/31/20202,590,200 shares $12.32 million -1.3%N/A221.4 $4.76
8/14/20202,625,200 shares $13.43 million +0.7%N/A276.3 $5.12
7/31/20202,606,000 shares $13.59 million -3.9%N/A2004.6 $5.22
7/15/20202,712,700 shares $13.92 million +3.3%N/A1043.3 $5.13
6/30/20202,626,200 shares $14.05 million -0.3%N/A937.9 $5.35
6/15/20202,634,400 shares $13.22 million -2.5%N/A13172 $5.02
5/29/20202,702,300 shares $14.79 million -1.0%N/A27023 $5.47
5/15/20202,728,100 shares $14.43 million +10.0%N/A13640.5 $5.29
4/30/20202,480,300 shares $13.84 million +2.0%N/A729.5 $5.58
4/15/20202,432,900 shares $11.99 million +3.1%N/A1158.5 $4.93
3/31/20202,361,000 shares $13.43 million +8.6%N/A4722 $5.69
3/13/20202,174,400 shares $10.96 million -0.3%N/A258.9 $5.04
2/28/20202,180,000 shares $10.90 million +1.4%N/A660.6 $5.00
2/14/20202,150,300 shares $10.30 million -4.7%N/A212.9 $4.79
1/31/20202,256,500 shares $13.50 million -2.2%N/A1880.4 $5.98
1/15/20201,511,000 shares $8.69 million -9.0%N/A3022 $5.75
12/31/20191,661,200 shares $9.97 million -0.3%N/A48.7 $6.00

KHTRF Short Interest - Frequently Asked Questions

What is Knight Therapeutics' current short interest?

Short interest is the volume of Knight Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 345,200 shares of KHTRF short. Learn More on Knight Therapeutics' current short interest.

What is a good short interest ratio for Knight Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KHTRF shares currently have a short interest ratio of 119.0. Learn More on Knight Therapeutics's short interest ratio.

Is Knight Therapeutics' short interest increasing or decreasing?

Knight Therapeutics saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 345,200 shares, an increase of 34.8% from the previous total of 256,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Knight Therapeutics stock?

Short selling KHTRF is an investing strategy that aims to generate trading profit from Knight Therapeutics as its price is falling. KHTRF shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Knight Therapeutics?

A short squeeze for Knight Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KHTRF, which in turn drives the price of the stock up even further.

How often is Knight Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KHTRF, twice per month. The most recent reporting period available is October, 31 2024.




This page (OTCMKTS:KHTRF) was last updated on 11/18/2024 by MarketBeat.com Staff
From Our Partners